Hydroxocobalamin Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Hydroxocobalamin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 4, 2024. Reported reason: Other

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-2888-30
Dosage Form
Injection
Presentation
Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)
Initial Posting
Nov 4, 2024

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.